Molecular fields in drug discovery: getting old or reaching maturity?

Area of Science:

• Computational chemistry
• Medicinal chemistry
• Drug discovery

Background:

• The advent of GRID and Comparative Molecular Field Analysis (CoMFA) introduced molecular field methods to drug discovery.
• These techniques, now in their third decade, revolutionized early-stage drug design by analyzing molecular interactions.

Purpose of the Study:

• To critically evaluate the current applicability and future potential of molecular field-based methods in contemporary drug discovery.
• To address whether these established techniques are becoming obsolete or are evolving into more powerful tools.

Main Methods:

• Review of established molecular field techniques, including GRID and CoMFA.
• Analysis of their historical impact and adaptation to modern computational drug discovery workflows.
• Assessment of their integration with emerging technologies and methodologies.

Main Results:

• Molecular field methods remain relevant due to their ability to model specific molecular interactions.
• Adaptations and advancements have enhanced their utility in contemporary drug discovery pipelines.
• These methods are not outdated but are maturing, offering continued value.

Conclusions:

• Molecular field-based methods, despite their age, continue to be valuable assets in drug discovery.
• Their ongoing development and integration with new technologies ensure their sustained applicability.
• These techniques are evolving, not declining, and offer significant potential for future drug design.